Founder & CEO

Atlas Venture raises $400M to invest in later-stage biotechs

Meet Australia’s newest employees: they’re digital and they’re brilliant

STAT+: What Baby KJ means for the CRISPR gene editing industry

Q1 Biopharma Layoffs Hit California, Massachusetts Hard

Principal CMC Data Scientist

Intellia is committed to developing curative genome editing treatments for severe diseases. The Principal CMC Data Scientist will lead the application of advanced statistical methodologies to support the pharmaceutical development lifecycle, particularly in process verification and data management for therapeutic products.

Sign up with Google

Sign in with Google